SEC Company Response from BioCardia, Inc. (BCDA) (CIK 0000925741) (BCDA) — Jul 24, 2019
BioCardia, Inc. (BCDA) (CIK 0000925741)
Date: July 24, 2019 · CIK: 0000925741 · Accession: 0001437749-19-014551
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-230779
Letter
bcda20190724_corresp.htm
July 24, 2015
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549-3720
Attention: Jeffrey Gabor
Re:
BioCardia, Inc.
Registration Statement on Form S-1
Filed on July 23, 2019
File No. 333-230779
Ladies and Gentlemen:
BioCardia, Inc. (the “Company”) hereby respectfully requests withdrawal of its acceleration request filed on July 23, 2019 relating to its Registration Statement on Form S-1 (File No. 333-230779) (the “Registration Statement”). The Company is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.
If you have any questions regarding the foregoing, please contact our counsel, Nathan Robinson of Wilson Sonsini Goodrich and Rosati, Professional Corporation, at (512) 418-6483.
Sincerely,
BIOCARDIA, INC.
Show Raw Text
CORRESP 1 filename1.htm bcda20190724_corresp.htm July 24, 2015 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549-3720 Attention: Jeffrey Gabor Re: BioCardia, Inc. Registration Statement on Form S-1 Filed on July 23, 2019 File No. 333-230779 Ladies and Gentlemen: BioCardia, Inc. (the “Company”) hereby respectfully requests withdrawal of its acceleration request filed on July 23, 2019 relating to its Registration Statement on Form S-1 (File No. 333-230779) (the “Registration Statement”). The Company is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date. If you have any questions regarding the foregoing, please contact our counsel, Nathan Robinson of Wilson Sonsini Goodrich and Rosati, Professional Corporation, at (512) 418-6483. Sincerely, BIOCARDIA, INC. By: /s/ David McClung Name: David McClung Title: Chief Financial Officer